Parenteral formulations of peptides for the treatment of systemic lupus erythematosus

Details for Australian Patent Application No. 2004206842 (hide)

Owner Teva Pharmaceutical Industries, Ltd.

Inventors Naftali, Esmira; Weinstein, Vera; Gilbert, Adrian; Klinger, Ety; Cohen-Vered, Sharon

Agent FB Rice

Pub. Number AU-A-2004206842

PCT Pub. Number WO2004/064787

Priority 60/439,918 14.01.03 US

Filing date 14 January 2004

Wipo publication date 5 August 2004

International Classifications

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

25 August 2005 PCT application entered the National Phase

  PCT publication WO2004/064787 Priority application(s): WO2004/064787

5 February 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004206844-Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus

2004206837-Article for debridement and detoxification of wounds